A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology [2]

A. Ottaiano; A. Budillon; N. Normanno; V. R. Iaffaioli; Michele Caraglia

doi:10.1093/annonc/mdm115

A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology [2]

A. Ottaiano, A. Budillon, N. Normanno, V. R. Iaffaioli, Michele Caraglia

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	960-961
Number of pages	2
Journal	Annals of Oncology
Volume	18
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdm115
Publication status	Published - May 2007

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/annonc/mdm115

Cite this

@article{a519e2b7b8214a3cb85a00234e3c06b7,

title = "A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology [2]",

author = "A. Ottaiano and A. Budillon and N. Normanno and Iaffaioli, {V. R.} and Michele Caraglia",

year = "2007",

month = may,

doi = "10.1093/annonc/mdm115",

language = "English",

volume = "18",

pages = "960--961",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "5",

}

TY - JOUR

T1 - A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology [2]

AU - Ottaiano, A.

AU - Budillon, A.

AU - Normanno, N.

AU - Iaffaioli, V. R.

AU - Caraglia, Michele

PY - 2007/5

Y1 - 2007/5

UR - http://www.scopus.com/inward/record.url?scp=34447304643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447304643&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdm115

DO - 10.1093/annonc/mdm115

M3 - Article

C2 - 17437968

AN - SCOPUS:34447304643

VL - 18

SP - 960

EP - 961

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

ER -

A multidisciplinary approach is required to increase the quality of phase II/III clinical studies on biotherapies in oncology [2]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this